Basic Information
ID: ALA4681811
Type: Binding
Description: Inhibition of protein interaction between C-terminal 6x-histidine tagged full-length beta-catenin (1 to 781 residues) (unknown origin)/N-terminal biotinylated human BCL9 ( 350 to 375 residues) incubated for 1 hr by Alpha-screen competitive inhibition assay
Format: BAO_0000223
Organism: Homo sapiens
Target: beta-catenin-B-cell lymphoma 9 protein complex(ALA3885525)
Document: ALA4680104
Inhibition of protein interaction between C-terminal 6x-histidine tagged full-length beta-catenin (1 to 781 residues) (unknown origin)/N-terminal biotinylated human BCL9 ( 350 to 375 residues) incubated for 1 hr by Alpha-screen competitive inhibition assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4681811
Ki
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 646.54 | 6.17 | 6.17 |
| 672.56 | 5.73 | 5.73 |
| 629.54 | 5.43 | 5.43 |
| 707.63 | 4.68 | 4.68 |
| 647.53 | 5.57 | 5.57 |
| 696.59 | 5.21 | 5.21 |
| 648.51 | 4.96 | 4.96 |
| 642.57 | 6.34 | 6.34 |
| 696.54 | 7.05 | 7.05 |
| 721.65 | 5.40 | 5.40 |
| 696.59 | 5.21 | 5.21 |
| 642.57 | 6.34 | 6.34 |
| 653.56 | 5.90 | 5.90 |
| 647.53 | 5.57 | 5.57 |
| 672.56 | 5.73 | 5.73 |
| 671.57 | 5.13 | 5.13 |
| 671.57 | 5.13 | 5.13 |
| 642.57 | 6.34 | 6.34 |
| 678.61 | 7.19 | 7.19 |
| 685.60 | 5.99 | 5.99 |
| 690.55 | 5.87 | 5.87 |
| 647.53 | 5.57 | 5.57 |
| 653.56 | 5.90 | 5.90 |
| 666.65 | 7.11 | 7.11 |
| 614.59 | 6.18 | 6.18 |
| 684.60 | 7.06 | 7.06 |
| 660.56 | 6.48 | 6.48 |
| 654.56 | 7.13 | 7.13 |
| 616.60 | 6.27 | 6.27 |
| 696.59 | 5.21 | 5.21 |
| 654.56 | 7.13 | 7.13 |
| 716.70 | 6.15 | 6.15 |